Free Trial

Profound Medical (PROF) Competitors

Profound Medical logo
$4.99 +0.10 (+2.04%)
As of 04/30/2025 04:00 PM Eastern

PROF vs. KIDS, BBNX, TMCI, CLPT, DCTH, NPCE, SMLR, TCMD, NNOX, and STIM

Should you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include OrthoPediatrics (KIDS), Beta Bionics (BBNX), Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), NeuroPace (NPCE), Semler Scientific (SMLR), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry.

Profound Medical vs.

Profound Medical (NASDAQ:PROF) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Profound Medical presently has a consensus target price of $11.50, indicating a potential upside of 130.46%. OrthoPediatrics has a consensus target price of $37.00, indicating a potential upside of 77.71%. Given Profound Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Profound Medical is more favorable than OrthoPediatrics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profound Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
OrthoPediatrics
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

OrthoPediatrics has higher revenue and earnings than Profound Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Profound Medical$10.68M14.04-$28.57M-$1.12-4.46
OrthoPediatrics$204.73M2.47-$20.97M-$1.63-12.77

Profound Medical has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.

OrthoPediatrics has a net margin of -15.00% compared to Profound Medical's net margin of -349.41%. OrthoPediatrics' return on equity of -5.78% beat Profound Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Profound Medical-349.41% -85.22% -64.87%
OrthoPediatrics -15.00%-5.78%-4.80%

In the previous week, Profound Medical had 12 more articles in the media than OrthoPediatrics. MarketBeat recorded 15 mentions for Profound Medical and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.71 beat Profound Medical's score of 0.17 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Profound Medical
1 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
OrthoPediatrics
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

OrthoPediatrics received 274 more outperform votes than Profound Medical when rated by MarketBeat users. However, 73.21% of users gave Profound Medical an outperform vote while only 64.42% of users gave OrthoPediatrics an outperform vote.

CompanyUnderperformOutperform
Profound MedicalOutperform Votes
41
73.21%
Underperform Votes
15
26.79%
OrthoPediatricsOutperform Votes
315
64.42%
Underperform Votes
174
35.58%

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

OrthoPediatrics beats Profound Medical on 11 of the 19 factors compared between the two stocks.

Get Profound Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PROF vs. The Competition

MetricProfound MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$149.96M$4.39B$5.57B$7.83B
Dividend YieldN/A39.98%5.11%4.22%
P/E Ratio-3.7230.6722.4418.48
Price / Sales14.0454.91394.09103.59
Price / CashN/A51.0838.1834.62
Price / Book3.906.116.774.25
Net Income-$28.57M$68.15M$3.22B$248.23M
7 Day Performance5.72%-0.12%1.49%0.89%
1 Month Performance-14.70%-2.24%4.00%3.53%
1 Year Performance-33.02%24.15%16.21%5.08%

Profound Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PROF
Profound Medical
2.2439 of 5 stars
$4.99
+2.0%
$11.50
+130.5%
-32.9%$149.96M$10.68M-3.72150Upcoming Earnings
KIDS
OrthoPediatrics
4.1805 of 5 stars
$21.77
+1.1%
$37.00
+70.0%
-29.7%$528.73M$204.73M-17.70200Upcoming Earnings
BBNX
Beta Bionics
N/A$10.80
-1.5%
$24.83
+129.9%
N/A$468.17M$65.12M0.00294
TMCI
Treace Medical Concepts
2.6111 of 5 stars
$6.90
+2.7%
$9.93
+43.9%
-31.7%$433.94M$209.36M-6.97250Upcoming Earnings
CLPT
ClearPoint Neuro
2.103 of 5 stars
$14.71
+0.1%
$25.00
+70.0%
+165.0%$411.59M$31.39M-21.32110
DCTH
Delcath Systems
2.8599 of 5 stars
$12.00
-0.9%
$22.75
+89.6%
+131.5%$401.20M$37.21M-8.8960Short Interest ↑
Positive News
NPCE
NeuroPace
3.8549 of 5 stars
$11.62
+4.2%
$15.20
+30.8%
-10.0%$380.59M$79.91M-11.62170Upcoming Earnings
Short Interest ↓
Positive News
SMLR
Semler Scientific
3.1489 of 5 stars
$35.37
-4.0%
$71.00
+100.7%
+26.6%$339.45M$56.29M7.20120Upcoming Earnings
Gap Down
TCMD
Tactile Systems Technology
2.9369 of 5 stars
$14.17
-2.8%
$18.00
+27.0%
+2.5%$335.35M$292.98M20.24980Upcoming Earnings
NNOX
Nano-X Imaging
2.5704 of 5 stars
$5.15
-1.9%
$12.00
+133.0%
-43.9%$297.56M$11.28M-6.06190Positive News
Gap Down
STIM
Neuronetics
2.2063 of 5 stars
$4.45
-0.7%
$5.50
+23.6%
+30.0%$292.88M$74.89M-3.62180Upcoming Earnings
News Coverage

Related Companies and Tools


This page (NASDAQ:PROF) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners